日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

10: Investigating the mechanisms of neoadjuvant olaparib and cediranib in renal cancer: results of arms 1 to 3 of the WIndow of opportunity in REnal cancer (WIRE) clinical trial

10:探讨新辅助奥拉帕尼和西地尼布治疗肾癌的机制:肾癌机会窗口(WIRE)临床试验第1至3组的结果

Herrmann, Tim; Mallow, Johannes; Plaumann, Markus; Lehmann, Rüdiger; Baecke, Sebastian; Berger, Jakob; Rak, Marko; Franke, Martin; Heinrich, Philipp; Tiller, Daniel; Pirkl, Anna; Bernarding, Johannes; Bruns, Christian; Jones, James; Wray, Rebecca; Menih, Ines Horvat; Thomas, Martin; Said, Sulekha; Mossop, Helen; Aquino, Maria; Arimtage, James; Baker, Harriet; Batley, Carley; Blackmur, James; Burge, Sarah; Chhabra, Anita; Easita, Farhana; Eisen, Tim; Fife, Kate; Godoy, Angela; Goodwin, Richard; Ince, Will; John, Rose; Laird, Alexander; Lukashchuk, Natalia; Matakidou, Athena; Mitchell, Thomas; Priest, Andrew; Protheroe, Andrew; Ranjit, Sreenidhi; Riddick, Anthony; Sipple, Jamal; Strong, Amy; Su, Helen; Sullivan, Mark; Tarantino, Silvia; Tsang-Pells, Gemma; Ursprung, Stephan; Wallis, Lauren; Warren, Anne; Wason, James; Welsh, Sarah; Kim, Younghwa; Stone, John; Crispin-Ortuzar, Mireia; Gallagher, Ferdia

Detection of p53 aggregates in plasma of glioma patients.

检测胶质瘤患者血浆中的p53聚集体

Wu Yunzhao, Lam Jeff Y L, Pitoulias Matthaios, Böken Dorothea, Zhang Ziwei, Chintapalli Renuka, Fertan Emre, Xia Zengjie, Danial John S H, Tsang-Pells Gemma, Fysh Emily, Julian Linda, Brindle Kevin M, Mair Richard, Klenerman David